EDGAR Filing Documents for 0001171843-17-001931

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-17-001931

Filing Date

2017-04-03

Accepted

2017-04-03 17:29:45

Documents

Period of Report

2017-05-11

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_040317.htm	6-K	333402
2	GRAPHIC	logo.jpg	GRAPHIC	8965
3	GRAPHIC	proxy_01.jpg	GRAPHIC	198966
4	GRAPHIC	proxy_02.jpg	GRAPHIC	102703
	Complete submission text file	0001171843-17-001931.txt		762506

Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739

Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131

RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 17735417
SIC: 2834 Pharmaceutical Preparations